glp-1 drugs and dementia Could diabetes weight loss treat Alzheimer's disease? GLP-1 Drug Fails to Quell

There are a large number of studies that have reported the application of exendin-4, liraglutide and exenatide in the treatment of cognitive dysfunction and pathological features in AD models

For a detailed breakdown of what to expect during each week of treatment, see our retatrutide week-by-week timeline guide

Gradual, sustainable weight loss can help reduce inflammatory stress that worsens autoimmune symptoms

However, the broad distribution of GLP-1 receptors across various tissues, such as the pancreas, lungs, kidneys, central nervous system, cardiovascular system, gastrointestinal tract, skin, and thyroid gland, has raised concerns about the potential impact of GLP-1 RAs on cancer development and progression [23]